ISDA

Deposition Date 2010-10-22

Release Date 2011-10-05

Last Version Date 2024-02-21

Entry Detail

PDB ID:

3PDJ

Keywords:

OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR

Title:

Crystal Structure of Human 11-beta-Hydroxysteroid Dehydrogenase 1 (11b-HSD1) in Complex with 4,4-Disubstituted Cyclohexylbenzamide Inhibitor

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.30 Å

R-Value Free:

0.24

R-Value Work:

0.21

R-Value Observed:

0.21

Space Group:

P 31 2 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Corticosteroid 11-beta-dehydrogenase isozyme 1
Gene (Uniprot):HSD11B1
Mutations:C272S
Chain IDs:A, B
Chain Length:273
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:P28845 Pfam ID:PF00106 EC:1.1.1.146

Ligand Molecules

3PJ

NAP

Primary Citation

Synthesis and Optimization of Novel 4,4-Disubstituted Cyclohexylbenzamide Derivatives as Potent 11beta-HSD1 Inhibitors

Sun, D, Wang, Z, Caille, S, DeGraffenreid, M, Gonzalez-Lopez de Turiso, F, Hungate, R, Jaen, J.C, Jiang, B, Julian, L.D, Kelly, R, McMinn, D.L, Kaizerman, J, Rew, Y, Sudom, A, Tu, H, Ursu, S, Walker, N, Willcockson, M, Yan, X, Ye, Q, Powers, J.P.Show

Bioorg.Med.Chem.Lett. 21 405 410 (2011)

PMID: 21093258 DOI: 10.1016/j.bmcl.2010.10.129

Abstact

The synthesis and SAR of a series of 4,4-disubstituted cyclohexylbenzamide inhibitors of 11β-HSD1 are described. Optimization rapidly led to potent, highly selective, and orally bioavailable inhibitors demonstrating efficacy in both rat and non-human primate ex vivo pharmacodynamic models.

Legend

Protein

Chemical

Disease

Primary Citation of related structures